26.02.2014 • News • BASF • Dede Willams • Dow

BASF Has No Plans to Revive Share Buyback Scheme

Unlike U.S. rivals such as Dow Chemical and DuPont, BASF has no plans to revive its share buyback program, the German group's CEO Kurt Bock told Reuters Inside TV.

Interviewed in conjunction with the annual results press conference in Ludwigshafen on Feb. 25, Bock said BASF would prefer to spend the money on new plant and equipment.

"We pay a handsome dividend and then the money is being spent, frankly," the news agency quotes Bock as saying. "We are rightly leveraged, there is little money left for buybacks." From 1999-2008, BASF purchased around €10 billion worth of its own stock.

Bock said also that the group would continue to focus on technology-driven, smaller acquisitions.

Interview

Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Innovation Pitch

Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.